MUS
TEVA icon

Mitsubishi UFJ Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Mitsubishi UFJ Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-45,600
Closed -$2.29M – 229
2016
Q2 		$2.29M Buy
45,600
+42,300
+1,282% +$2.25M 4.05% 3
2016
Q1 		$177K Buy
+3,300
New +$194K 0.23% 52

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mitsubishi UFJ Securities's TEVA Position: Q3 2016 in Review

Mitsubishi UFJ Securities sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 45,600 shares — an estimated $2.29M sold.

Mitsubishi UFJ Securities first reported a position in TEVA in Q1 2016 and held it in 2 quarters. The position peaked at $2.29M in Q2 2016. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Mitsubishi UFJ Securities reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Mitsubishi UFJ Securities sold 45,600 Teva Pharmaceuticals shares in Q3 2016, an estimated $2.29M.
  • Mitsubishi UFJ Securities first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Mitsubishi UFJ Securities's Teva Pharmaceuticals position peaked at $2.29M in Q2 2016.
  • 795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Mitsubishi UFJ Securities's 13F filing for Q3 2016, filed 8 Nov 2016.